HIF-1α C1772T polymorphism and gastrointestinal tract cancer risk: A meta-analysis and meta-regression analysis

Genetic Testing and Molecular Biomarkers

Volumn 17, Issue 12, 2013, Pages 918-925

  Xu, Jian ^a   Xu, Liang ^a   Li, Lintao ^a   You, Qing ^a   Cha, Luosi ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ARTICLE; ASIAN; CANCER PATIENT; CANCER RISK; CAUCASIAN; DIGESTIVE SYSTEM CANCER; ETHNICITY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HIF 1ALPHA GENE; HUMAN; TUMOR GENE;

ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GASTROINTESTINAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; NEOPLASM PROTEINS; RISK FACTORS;

EID: 84889053212     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2013.0325     Document Type: Article

References (31)

1. Aiello M, Vella N, Cannavo C, et al. (2011) Role of genetic polymorphisms and mutations in colorectal cancer therapy (Review). Mol Med Rep 4:203-208.
2. Bernstein H, Bernstein C, Payne CM, et al. (2009) Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol 15:3329-3340.
3. Chiche J, Brahimi-Horn MC, Pouyssegur J (2010) Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. J Cell Mol Med 14:771-794.
4. da Costa BR, Cevallos M, Altman DG, et al. (2011) Uses and misuses of the STROBE statement: bibliographic study. BMJ Open 1:e000048.
5. Denko NC (2008) Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer 8:705-713.
6. Ferlay J, Shin HR, Bray F, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917.
7. Fransen K, Fenech M, Fredrikson M, et al. (2006) Association between ulcerative growth and hypoxia inducible factor-1 alpha polymorphisms in colorectal cancer patients. Mol Carcinog 45:833-840. (Pubitemid 44646335)
8. Gohlke JM, Thomas R, Zhang Y, et al. (2009) Genetic and environmental pathways to complex diseases. BMC Syst Biol 3:46.
9. Ioannidis JP, Patsopoulos NA, Rothstein HR (2008) Reasons or excuses for avoiding meta-analysis in forest plots. BMJ 336:1413-1415.
10. Jackson D, White IR, Riley RD (2012) Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med 31:3805-3820.
11. Jemal A, Bray F, Center MM, et al. (2011) Global cancer statistics. CA Cancer J Clin 61:69-90.
12. Kang MJ, Jung SA, Jung JM, et al. (2011) Associations between single nucleotide polymorphisms of MMP2, VEGF, and HIF1A genes and the risk of developing colorectal cancer. Anticancer Res 31:575-584.
13. Knechtel G, Szkandera J, Stotz M, et al. (2010) Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk. Mol Carcinog 49:805-809.
14. Kuwai T, Kitadai Y, Tanaka S, et al. (2004) Single nucleotide polymorphism in the hypoxia-inducible factor-1alpha gene in colorectal carcinoma. Oncol Rep 12:1033-1037.
15. Lao-Sirieix P, Caldas C, Fitzgerald RC (2010) Genetic predisposition to gastro-oesophageal cancer. Curr Opin Genet Dev 20:210-217.
16. Li K, Zhang Y, Dan Z, et al. (2009) Association of the hypoxia inducible factor-1alpha gene polymorphisms with gastric cancer in Tibetans. Biochem Genet 47:625-634.
17. Ling TS, Shi RH, Zhang GX, et al. (2005) Common single nucleotide polymorphism of hypoxia-inducible factor-1alpha and its impact on the clinicopathological features of esophageal squamous cell carcinoma. Chin J Dig Dis 6:155-158.
18. Loh M, Koh KX, Yeo BH, et al. (2009) Meta-analysis of genetic polymorphisms and gastric cancer risk: variability in associations according to race. Eur J Cancer 45:2562-2568.
19. Luczak MW, Roszak A, Pawlik P, et al. (2011) Increased expression of HIF-1A and its implication in the hypoxia pathway in primary advanced uterine cervical carcinoma. Oncol Rep 26:1259-1264.
20. Macarthur M, Hold GL, El-Omar EM (2004) Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 286: G515-G520. (Pubitemid 38374969)
21. Mucaj V, Shay JE, Simon MC (2012) Effects of hypoxia and HIFs on cancer metabolism. Int J Hematol 95:464-470.
22. Peters JL, Sutton AJ, Jones DR, et al. (2006) Comparison of two methods to detect publication bias in meta-analysis. JAMA 295:676-680. (Pubitemid 43209069)
23. Schito L, Rey S, Tafani M, et al. (2012) Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells. Proc Natl Acad Sci USA 109: E2707-E2716.
24. Semenza GL (2004) Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda) 19:176-182. (Pubitemid 39481932)
25. Thibault F, Cancel-Tassin G, Cussenot O (2006) Low penetrance genetic susceptibility to kidney cancer. BJU Int 98: 735-738. (Pubitemid 44368016)
26. Weidemann A, Johnson RS (2008) Biology of HIF-1alpha. Cell Death Differ 15:621-627.
27. Yamada N, Horikawa Y, Oda N, et al. (2005) Genetic variation in the hypoxia-inducible factor-1alpha gene is associated with type 2 diabetes in Japanese. J Clin Endocrinol Metab 90:5841-5847. (Pubitemid 41415501)
28. Zhao T, Lv J, Zhao J, et al. (2009) Hypoxia-inducible factor-1alpha gene polymorphisms and cancer risk: a meta-analysis. J Exp Clin Cancer Res 28:159.
29. Zhou J, Schmid T, Schnitzer S, et al. (2006) Tumor hypoxia and cancer progression. Cancer Lett 237:10-21.
30. Zinkernagel AS, Johnson RS, Nizet V (2007) Hypoxia inducible factor (HIF) function in innate immunity and infection. J Mol Med (Berl) 85:1339-1346. (Pubitemid 350234101)
31. Zintzaras E, Ioannidis JP (2005) HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics 21: 3672-3673. (Pubitemid 41264106)